Novo Nordisk CEO says investor confidence needs to be rebuilt to address patent expiry challenges
智通财经2026/09/22 08:06Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Novo Nordisk CEO Lars Fruergaard Jørgensen stated that, given the upcoming patent expirations for the company’s key drugs such as Ozempic in the early part of the next decade, the company must do more to build investor confidence. Jørgensen said: “What we have learned in the past few years is that overpromising and under-delivering quickly erodes trust.” Investors “want to know what’s coming next.” Novo Nordisk shares declined on Monday as the company’s capital markets day left investors disappointed over a lack of details regarding its turnaround plan. Novo Nordisk is facing patent expiry in the US and Europe for Ozempic and Wegovy, a product line that currently contributes around three-quarters of its sales. Novo Nordisk has pledged to launch more than five major new medications by 2030 and to achieve over $23 billion in additional sales by 2035. These targets are widely regarded as being in line with investor expectations. Analysts at BMO Capital Markets noted that Novo Nordisk is still in a period where it must prove itself through performance. Investors need clearer information about the company’s next-generation drugs and their potential market acceptance in order to rebuild confidence.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like

US stock market movement | Major bank stocks decline, JPMorgan (JPM.US) drops 3.7%
智通财经•2026/09/22 16:16
PayPal partners with Meta to enable shopping and checkout via Muse
智通财经•2026/09/22 15:41
Crypto prices
MoreBitcoin
BTC
$86,210.87
+0.47%
Ethereum
ETH
$2,733.48
-0.91%
Tether USDt
USDT
$1
+0.01%
BNB
BNB
$786.93
-1.67%
XRP
XRP
$1.55
+3.78%
USDC
USDC
$1
+0.02%
Solana
SOL
$116.89
-0.83%
TRON
TRX
$0.3410
-1.17%
Zcash
ZEC
$1,539.51
+2.72%
Hyperliquid
HYPE
$94.75
+1.89%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now